Clinical Trials Sponsored by BIOrest Ltd.

Total 19609 results

BIOrest Ltd.

Unknown

BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (BLADE)

Diabetes Mellitus

Israel
Biobeat Technologies Ltd.

Completed

Monitoring Patients With Acute Cardiac Disease Using a Wireless, Wearable, Non-invasive Monitor

Acute Cardiac Event | Acute Cardiac Failure | Acute Cardiac Pulmonary Edema

Israel
Biobeat Technologies Ltd.

Completed

Relation of Non-invasively Measured Parameters to Clinical Outcomes in CHF Patients

Congestive Heart Failure

Israel
Biobeat Technologies Ltd.

Completed

Comparing PPG-based Blood Pressure Measurement to the Gold Standard Manometer

Hypertension | Blood Pressure Disorders

Israel
Biobeat Technologies Ltd.

Completed

Early Warning of Intradialytic Hypotension in Hemodialysis Patients

Hypotension of Hemodialysis

Israel
Zimmer Biomet
Biomet U.K. Ltd.

Completed

A Randomized Control Trial to Assess Early Clinical and Functional Outcome of the ROCC and LCS Total Knee Implant Designs

Osteoarthritis

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Completed

A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty

Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Traumatic Arthritis

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Withdrawn

Retrospective Data Review of ReCap Total Hip Resurfacing

Osteoarthritis of the Hip
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

Retrieval Study and Histological Examination Of A Hip Femoral Components With Hydroxyapatite Coatings

Femoral Neck Fractures

United Kingdom
Zimmer Biomet
Biomet U.K. Ltd.

Terminated

ReCap Total Hip Resurfacing Prospective Data Collection

Arthritis

United Kingdom
Zimmer Biomet
Hvidovre University Hospital; Biomet U.K. Ltd.

Withdrawn

Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures

Osteoarthritis
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in Patients With Chronic Stable Schizophrenia

Schizophrenia

United States, India, Malaysia, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Schizophrenia

Schizophrenia

United States, Colombia, India, South Africa
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression

Bipolar Depression

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania

Bipolar Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Puerto Rico
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Study of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Colombia, India, Romania, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Long-term Safety and Tolerability of Cariprazine for Bipolar I Disorder

Bipolar I Disorder

United States, Hungary, Poland, Spain
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine (RGH-188) in the Acute Exacerbation of Schizophrenia

Schizophrenia

United States, India, Russian Federation, Malaysia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Schizophrenia

United States, Romania, Russian Federation, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia

Schizophrenia

United States, India, Romania, Slovakia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

Major Depressive Disorder

United States, Estonia, Finland, Slovakia, Sweden, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Mania

Bipolar Disorder | Mania

United States, India
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder

Major Depressive Disorder

United States
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression

Depression, Bipolar

United States, Ukraine, Bulgaria, Canada, Colombia, Russian Federation
Forest Laboratories
Gedeon Richter Ltd.

Completed

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Mania | Bipolar I Disorder

United States, Croatia, Romania, Russian Federation, Serbia, Ukraine
Forest Laboratories
Gedeon Richter Ltd.

Completed

Study of the Safety and Efficacy of RGH-896 in Patients With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathic Pain

United States
Biobeat Technologies Ltd.
Sheba Medical Center

Completed

Early Identification of Clinical Deterioration Using a Wearable Monitoring Device

Hemodynamic Instability | Clinical Deterioration

Israel
Biobeat Technologies Ltd.
Hadassah Medical Organization

Completed

Comparing Cardiac Output Measurements Using a Wearable, Wireless, Non-invasive PPG-Based Device to a Swan Ganz Catheter

Congestive Heart Failure | Cardiac Output, Low | Cardiac Output, High

Israel
Biotest Pharmaceuticals Corporation
Biotest

Completed

Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

Multiple Myeloma

United States
Biotest Pharmaceuticals Corporation
Biotest

Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United States
Phoenix Neurological Associates, LTD
Forest Laboratories

Completed

Memantine Therapy in Amyotrophic Lateral Sclerosis (TAME)

Amyotrophic Lateral Sclerosis

United States
Mahidol University
BioNet-Asia Co., Ltd.

Completed

5-year Follow-up After a Single Dose Acellular Pertussis Vaccination

Pertussis

Thailand
Biotest

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP) (ESsCAPE)

Community-acquired Pneumonia

Australia, Spain, Israel, France, Brazil, Germany, United States, Philippines, Belgium, Romania, Czechia, Hungary, Austria, Argentina, South Africa
Biotest

Recruiting

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

COVID-19 | Pneumonia | Acute Respiratory Distress Syndrome | Community-acquired Pneumonia | Respiratory Infection | Bacterial Pneumonia | Viral Pneumonia | Fungal Pneumonia

Belgium, Brazil, Latvia, Germany, Lithuania, South Africa, Argentina, Austria, France, Hungary, Slovakia, Turkey, Portugal, Spain
Biotest

Active, not recruiting

Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion) (PreCyssion)

Congenital Cytomegalovirus Infection

Germany
Biotest

Completed

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19 (ESsCOVID)

Covid19

Brazil, France, Russian Federation, Spain
Biotest

Completed

Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus (BT063 in SLE)

Systemic Lupus Erythematosus

Belarus, Georgia, Poland, Serbia
Biotest

Completed

Safety and Efficacy Study of BT086 to Evaluate Adjunctive Therapy in sCAP (CIGMA)

Community Acquired Pneumonia

Germany, Belgium, Spain, United Kingdom
Biotest

Completed

Dose-finding of Multiple Dose of BT061 in Patients With Active Rheumatoid Arthritis Incompletely Controlled on Stable Methotrexate (MTX)

Rheumatoid Arthritis

Poland, Czech Republic, Germany, Hungary, Italy, Latvia, Spain
Zimmer Biomet
East Sussex Hospitals NHS Trust; Biomet U.K. Ltd.

Active, not recruiting

Randomized Controlled Clinical Evaluation to Compare Vanguard Cruciate Retaining and AGC Total Condylar Knee Implants (Vanguard)

Osteoarthritis | Rheumatoid Arthritis | Traumatic Arthritis

United Kingdom
Biotest

Completed

Safety and Efficacy of Multiple Doses of BT061 in Patients With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis Vulgaris

Czech Republic, Hungary
Mayne Pharma International Pty Ltd
bioRASI, LLC

Completed

A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice

Head Lice

United States
Mayne Pharma International Pty Ltd
bioRASI, LLC

Completed

Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.

Scabies

United States
Biobeat Technologies Ltd.
Assaf-Harofeh Medical Center

Completed

Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients

Critically Ill | Hemodynamic Instability

Israel
Wake Forest University Health Sciences
NovoCure Ltd.

Terminated

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Cancer of Brain and Nervous System

United States
Biobeat Technologies Ltd.
The Chaim Sheba Medical Center

Recruiting

Comparison of Non-Invasive Blood Pressure (NIBP) Using the Biobeat Device With an Invasive Arterial Line Catheter

Heart Diseases | Blood Pressure

Israel
Biotest
AbbVie

Terminated

Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis (986)

Rheumatoid Arthritis

United States, Bulgaria, Canada, Czechia, Estonia, Germany, Hungary, Lithuania, Mexico, Poland, Russian Federation, Serbia, Slovakia, Ukraine

Clinical Trials Sponsored by BIOrest Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations